https://sam.gov/opp/aba80cf5f5254a4981a0b6a359e47239/view
Canaccord Genuity Maintains Buy on Inari Medical, Raises Price Target to $80
Canaccord Genuity analyst William Plovanic maintains Inari Medical (NASDAQ:NARI) with a Buy and raises the price target from $77 to $80.